Dr. Ashley Drews, MD

Dr. Drews practices at Houston Methodist Hospital in Houston, Texas, part of Houston Methodist.

Dr. Drews' NPI, 1275613515, was assigned on October 17, 2006. Dr. Drews graduated from Baylor College Of Medicine in 1992. Dr. Drews holds Texas license K2449.

Dr. Drews' primary practice is Houston Methodist Hospital, at 6565 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 790-2221.

Dr. Drews' primary practice is Houston Methodist Hospital in Houston, Texas, part of Houston Methodist. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Drews to 2 more group practices and clinics, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Drews practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Drews' primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Drews is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Drews' licenses on file in 2 states: Texas and Massachusetts.

Dmand AI lists acute skin infection and hiv/aids among the conditions Dr. Drews treats.

CMS data shows 354 Medicare services from Dr. Drews across 3 procedure codes in 2024, for 128 Medicare patients. Medicare paid $24,015 for them.

CMS counts 128 Medicare patients who saw Dr. Drews in 2024. The largest group is 75 to 84, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Drews' median patient age at 73, with 45% women.

In 2024, Dr. Drews wrote 316 Medicare Part D claims for 47 patients. 77% of them were for generic drugs. CMS names the drug for 217 of them, across 15 drugs with 11 or more claims each, at $231,334 in total drug cost. In 2023, CMS named 209 claims across 13 drugs.

Dr. Drews accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Drews as offering telehealth.

Dmand AI links 11 papers to Dr. Drews, published from 2011 to 2024. 2023 was the busiest year, with 3. The most frequent topics are COVID-19, SARS-CoV-2 and Antibodies, Monoclonal. Dr. Drews has published most often in JAMA Netw Open. Dr. Drews' most frequent co-authors are James Mallory Musser, MD, PhD, Alpesh Navin Amin, MD and Monica Marie Bertagnolli, MD.

CMS Open Payments shows 5 general payments to Dr. Drews from 3 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 53% of the total. Merck Sharp & Dohme Corporation paid the most, $28.

Dmand AI lists 2 awards for Dr. Drews, most recently Top Doctors:SE Texas in 2013.

Dr. Drews graduated from Baylor College Of Medicine in 1992. Dr. Drews is a member of ACP.

Dr. Drews is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.